These diabetes-like drugs might help ease joint pain and slow down damage in arthritis by reducing pain, swelling, and joint breakdown.
Evidence from Studies
Supporting (3)
Community contributions welcome
Liraglutide, a glucagon-like peptide 1 receptor agonist, exerts analgesic, anti-inflammatory and anti-degradative actions in osteoarthritis
The study tested a diabetes drug called liraglutide, which is a type of GLP-1 drug, in mice with osteoarthritis and found it reduced pain, inflammation, and joint damage—just like the claim says.
Effect of glucagon-like peptide-1 receptor agonists in osteoarthritis: A systematic review of pre-clinical and human studies
The study looked at the same drugs mentioned in the claim and found they may help with joint protection, reduce inflammation, and possibly reduce pain in osteoarthritis, especially in animal studies.
The potential role of GLP‐1 receptor agonists in osteoarthritis
The study looks at the same drugs mentioned in the claim and finds they help with joint pain, reduce swelling, and may protect cartilage in arthritis patients.
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.